Insider Transactions in Q3 2024 at National Health Investors Inc (NHI)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 27
2024
|
W Andrew Adams Director |
SELL
Other acquisition or disposition
|
Indirect |
12,635
-100.0%
|
-
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
48,665
-45.65%
|
$4,087,860
$84.66 P/Share
|
|
Sep 25
2024
|
Kristin Sallee Gaines SVP/Chief Transaction Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,000
+17.55%
|
$3,795,000
$69.2 P/Share
|
|
Sep 18
2024
|
David L Travis SVP/Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,406
-39.33%
|
$884,510
$85.15 P/Share
|
|
Sep 18
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+16.05%
|
$828,000
$69.2 P/Share
|
|
Sep 05
2024
|
D. Eric Mendelsohn CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
130,461
-59.5%
|
$10,697,802
$82.1 P/Share
|
|
Sep 05
2024
|
D. Eric Mendelsohn CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
164,999
+16.91%
|
$8,909,946
$54.57 P/Share
|
|
Sep 03
2024
|
Robert T Webb Director |
SELL
Payment of exercise price or tax liability
|
Indirect |
52,353
-46.74%
|
$4,188,240
$80.04 P/Share
|
|
Sep 03
2024
|
Robert T Webb Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
70,000
+16.42%
|
$4,060,000
$58.77 P/Share
|
|
Sep 03
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
49,637
-56.35%
|
$4,020,597
$81.43 P/Share
|
|
Sep 03
2024
|
John L Spaid CFO/EVP Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
62,167
+13.51%
|
$3,357,018
$54.57 P/Share
|
|
Aug 23
2024
|
Kevin Carlton Pascoe Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
101,230
-64.45%
|
$7,895,940
$78.63 P/Share
|
|
Aug 23
2024
|
Kevin Carlton Pascoe Chief Investment Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
117,167
+12.82%
|
$7,030,020
$60.2 P/Share
|
|
Aug 23
2024
|
John L Spaid CFO/EVP Finance |
SELL
Payment of exercise price or tax liability
|
Direct |
65,463
-71.64%
|
$5,106,114
$78.63 P/Share
|
|
Aug 23
2024
|
John L Spaid CFO/EVP Finance |
BUY
Exercise of conversion of derivative security
|
Direct |
73,333
+23.84%
|
$4,766,645
$65.25 P/Share
|
|
Aug 23
2024
|
James R Jobe Director |
SELL
Payment of exercise price or tax liability
|
Direct |
31,289
-52.17%
|
$2,440,542
$78.63 P/Share
|
|
Aug 23
2024
|
James R Jobe Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+23.15%
|
$2,475,000
$55.3 P/Share
|
|
Aug 23
2024
|
David L Travis SVP/Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,839
-61.23%
|
$1,781,442
$78.63 P/Share
|
|
Aug 23
2024
|
David L Travis SVP/Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,300
+18.19%
|
$1,605,900
$53.58 P/Share
|
|
Aug 16
2024
|
Tracy M J Colden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+30.13%
|
$2,565,000
$57.31 P/Share
|
|
Aug 16
2024
|
Tracy M J Colden Director |
SELL
Payment of exercise price or tax liability
|
Direct |
35,143
-78.1%
|
$2,600,582
$74.29 P/Share
|
|
Jul 29
2024
|
Robert A Mccabe Jr Director |
SELL
Payment of exercise price or tax liability
|
Direct |
32,711
-49.13%
|
$2,453,325
$75.21 P/Share
|
|
Jul 29
2024
|
Robert A Mccabe Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
45,000
+21.0%
|
$2,475,000
$55.3 P/Share
|